Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capstone Therapeutics Corp

2.03
+0.01000.50%
Post-market: 2.060.0300+1.48%16:00 EDT
Volume:27.90K
Turnover:57.39K
Market Cap:10.54M
PE:-0.06
High:2.25
Open:2.03
Low:2.00
Close:2.02
Loading ...
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 12, 2025

Correspondence

Form CORRESP - Correspondence
Feb 06, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 06, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 25, 2025

Correspondence

Form CORRESP - Correspondence
Jan 01, 2025

Correspondence

Form CORRESP - Correspondence
Dec 31, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 09, 2019

Privatisation

SC 13E3/A [Amend] - Going private transaction by certain issuers
Aug 26, 2019

Major Issues Report

8-K - Current report
Aug 20, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 13, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 03, 2019

Privatisation

SC 13E3/A [Amend] - Going private transaction by certain issuers
Jul 03, 2019

Correspondence

CORRESP [Cover] - Correspondence
May 31, 2019

Privatisation

SC 13E3 - Going private transaction by certain issuers